The Strength study aim to evaluate the use of the RenalGuard device to protect the patients at high risk to develop acute kidney injury following a complex cardiovascular intervention requiring a high volume of contrast.
ID: NCT02793661
Sponsor
Countries
France, Germany
Number of investigational sites
7
Number of patients
300
